Alpha Tau reports promising Alpha DaRT trial results in pancreatic cancer and head and neck cancer, with significant survival benefits. High disease control rate (91% DCR) and positive interim safety ...
TipRanks on MSN
Alpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026
An update from Alpha Tau Medical Ltd ( ($DRTS) ) is now available. On January 6, 2026, Alpha Tau Medical reported final results from its ...
JP Morgan created the Global Data Assets & Alpha Group in 2019 to optimize the information used within trading. Composed of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback